Changes in Airway Sampling and Pseudomonas Aeruginosa Isolation after the Introduction of Elexacaftor/Tezacaftor/Ivacaftor
{{output}}
Background: The impact of Elexacaftor/Tezacaftor/Ivacaftor (ETI) on provision of airway samples, chronic infection definitions, and Pa isolation frequency/abundance in those with established chronic Pa infection pre-ETI is unknow... ...
